Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Chatziioannou, Aristotelis ^a   Georgiadis, Panagiotis ^a   Hebels, Dennie G ^b   Liampa, Irene ^a   Valavanis, Ioannis ^a   Bergdahl, Ingvar A ^c   Johansson, Anders ^c   Palli, Domenico ^d   Chadeau Hyam, Marc ^e   Siskos, Alexandros P ^f   Keun, Hector ^f   Botsivali, Maria ^a   De Kok, Theo M C M ^b   Pérez, Almudena Espín ^b   Kleinjans, Jos C S ^b   Vineis, Paolo ^e   Kyrtopoulos, Soterios A ^a   Gottschalk, Ralph ^b   Van Leeuwen, Danitsja ^b   Timmermans, Leen ^b   Bendinelli, Benedetta ^d   Kelly, Rachel ^e   Vermeulen, Roel ^g   Portengen, Lutzen ^g   Saberi Hosnijeh, Fatemeh ^g   Melin, Beatrice ^c   Hallmans, Goran ^c   Lenner, Per ^c   Athersuch, Toby J ^e,f   Kogevinas, Manolis ^h   Stephanou, Euripides G ⁱ   Myridakis, Antonis ⁱ   Fazzo, Lucia ^j   De Santis, Marco ^j   Comba, Pietro ^j   Kiviranta, Hannu ^k   Rantakokko, Panu ^k   Airaksinen, Riikka ^k   Ruokojarvi, Paivi ^k   Gilthorpe, Mark ^l   Fleming, Sarah ^l   Fleming, Thomas ^l   Tu, Yu Kang ^l   Jonsson, Bo ^m   Lundh, Thomas ^m   Chen, Wei J ⁿ   Lee, Wen Chung ⁿ   Hsiao, Chuhsing Kate ⁿ   Chien, Kuo Liong ⁿ   Kuo, Po Hsiu ⁿ   Hung, Hung ⁿ   Liao, Shu Fen ⁿ   more..

^a INSTITUTE OF BIOLOGY   (Greece)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UMEÅ UNIVERSITY   (Sweden)

^d Institute for Cancer Research and Prevention   (Italy)

^e Faculty of Medicine and MRC Health Protection Agency   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UTRECHT UNIVERSITY   (Netherlands)

^h CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

ⁱ UNIVERSITY OF CRETE   (Greece)

^j ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^k NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^l UNIVERSITY OF LEEDS   (United Kingdom)

^m LUND UNIVERSITY   (Sweden)

ⁿ NATIONAL TAIWAN UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; CPG ISLAND; DNA METHYLATION; DRUG EFFECT; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; HUMAN; MALE; MIDDLE AGED; PASSIVE SMOKING; PROCEDURES; SEX FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TOBACCO SMOKE POLLUTION;

EID: 85013857766     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42870     Document Type: Article

References (71)

1. US Department of Health and Human Services, The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, P1-978 (2014).
2. Huxley, R. R. & Woodward, M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378, 1297-305 (2011).
3. Appelman, Y., van Rijn, B. B., Ten Haaf, M. E., Boersma, E. & Peters, S. A. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 241, 211-8 (2015).
4. Peters, S. A., Huxley, R. R. & Woodward, M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 44, 2821-8 (2013).
5. Aryal, S., Diaz-Guzman, E. & Mannino, D. M. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 1145-54 (2014).
6. Forey, B. A., Thornton, A. J. & Lee, P. N. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm. Med. Jun 14, doi: 10.1186/1471-2466-11-36 (2011).
7. Kiyohara, C. & Ohno, Y. Sex differences in lung cancer susceptibility: a review. Gend. Med. 7, 381-401 (2010).
8. Papadopoulos, A. et al. Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study. Br. J. Cancer 110, 1385-91 (2014).
9. Powell, H. A., Iyen-Omofoman, B., Hubbard, R. B., Baldwin, D. R. & Tata, L. J. The association between smoking quantity and lung cancer in men and women. Chest 143, 123-9 (2013).
10. Georgiadis, P. et al. Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking. Sci. Rep. Feb 3, doi: 10.1038/srep20544 (2016).
11. Zeilinger, S. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 8, e638l2 (2013).
12. Shenker, I. M. S. et al. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with Smoking. Hum. Mol. Genet. 22, 843-851 (2013).
13. Leger, A. J., Covic, L. & Kuliopulos, A. Protease-activated receptors in cardiovascular diseases. Circulation 114, 1070-7 (2006).
14. Smith, S. M. et al. PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy. Platelets 16, 340-5 (2005).
15. Ramström, S. et al. Platelet PAR1 receptor density - correlation to platelet activation response and changes in exposure after platelet activation. Thromb. Res. 121, 681-8 (2007).
16. Li, R. & Emsley, J. The organizing principle of the platelet glycoprotein Ib-IX-V complex. J. Thromb. Haemost. 11, 605-14 (2013).
17. Senis, Y. A., Mazharian, A. & Mori, J. Src family kinases: at the forefront of platelet activation. Blood 124, 2013-24 (2014).
18. Crosby, D. & Poole, A. W. Physical and Functional Interaction between Protein Kinase Cδ and Fyn Tyrosine Kinase in Human Platelets. J. Biol. Chem. 278, 24533-24541 (2003).
19. Reddy, K. B., Smith, D. M. & Plow, E. F. Analysis of Fyn function in hemostasis and alphaIIbbeta3-integrin signaling. J. Cell Sci. 121, 1641-8 (2008).
20. Hers, I. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood 110, 4243-52 (2007).
21. Hsieh, H. L. et al. Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 29, 1594-601 (2009).
22. Cao, H., Dronadula, N. & Rao, G. N. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 290, C172-C182 (2006).
23. Lanzetti, L. et al. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature 408, 374-7 (2000).
24. Giampietro, C. et al. The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling. J. Cell Biol. 211, 1177-92 (2015).
25. Parrales, A., Lopez, E., Lee-Rivera, I. & Lopez-Colome, A. M. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation. Cell Signal. 25, 829-38 (2013).
26. Shende, P. et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123, 1073-82 (2011).
27. Haines, D. D., Lekli, I., Teissier, P., Bak, I. & Tosaki, A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol. (Oxf) 204, 487-501 (2012).
28. Wenzel, P. et al. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur. Heart J. 36, 3437-46 (2015).
29. Chan, K. H., Ng, M. K. & Stocker, R. Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 120, 493-504 (2011).
30. Dolinay, T., Choi, A. M. & Ryter, S. W. Heme Oxygenase-1/CO as protective mediators in cigarette smoke- induced lung cell injury and chronic obstructive pulmonary disease. Curr. Pharm/Biotechnol. 13, 769-76 (2012).
31. Wang, Z., Qin, G. & Zhao, T. C. HDAC4: mechanism of regulation and biological functions. Epigenomics 6, 139-50 (2014).
32. Parra, M. Class IIa HDACs - new insights into their functions in physiology and pathology. FEBS J. 282, 1736-44 (2015).
33. Vogler, M. et al. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 117, 7145-54 (2011).
34. Durante, A. & Zalewski, J. Microparticles: A novel player in cardiovascular diseases. Cardiology 132, 249-51 (2015).
35. Vandael, D. H. et al. Ca(v)1.3 and BK channels for timing and regulating cell firing. Mol. Neurobiol. 42, 185-98 (2010).
36. Mangoni, M. E. et al. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. USA 100, 5543-8 (2003).
37. Baig, S. M. et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat. Neurosci. 14, 77-84 (2011).
38. Zamponi, G. W. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat. Rev. Drug. Discov. 15, 19-3 (2016).
39. Im, B. H. & Rhim, H. GABA(B) receptor-mediated ERK1/2 phosphorylation via a direct interaction with Ca(V)1.3 channels. Neurosci. Lett. 513, 89-94 (2012).
40. Cepeda-Benito, A., Reynoso, J. T. & Erath, S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 72, 712-722 (2004).
41. Scharf, D. & Shiffman, S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and metaanalyses of clinical trials of Bupropion SR. Addiction 99, 1462-1469 (2004).
42. Chen, R. et al. Transcriptome profiling reveals that the SM22α -regulated molecular pathways contribute to vascular pathology. J. Mol. Cell Cardiol. 72, 263-72 (2014).
43. Banerjee, I. et al. Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response. PLoS Genet. Feb 20, doi: 10.1371/journal.pgen.1004114 (2014).
44. Puckelwartz, M. J. Nesprin-1 mutations in human and murine cardiomyopathy. J. Mol. Cell Cardiol. 48, 600-8 (2010).
45. Heinhuis, B. et al. Towards a role of interleukin-32 in atherosclerosis. Cytokine 64, 433-40 (2013).
46. Wang, H. et al. Cardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction. J. Lipid Res. 54, 953-65 (2013).
47. Shiffman, D. et al. Gene Variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 1613-1618 (2006).
48. Hakimzadeh, N. et al. Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function. PLoS One Sep 2, doi: 10.1371/journal.pone.0137035 (2015).
49. Chaireti, R., Gustafsson, K. M., Byström, B., Bremme, K. & Lindahl, T. L. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Hum Reprod. 28, 1846-52 (2013).
50. Farre, A. L., Modrego, J. & Zamorano-Leon, J. J. Effects of hormones on platelet aggregation. Horm. Mol. Biol. Clin. Investig. 18, 27-36 (2014).
51. Wang, T. Y. et al. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. J. Am. Coll. Cardiol. 59, 891-900 (2012).
52. Roy-OReilly, M. & McCullough, L. D. Sex differences in stroke: the contribution of coagulation. Exp. Neurol. 259, 16-27 (2014).
53. Gremmel, T., Kopp, C. W., Eichelberger, B., Koppensteiner, R. & Panzer, S. Sex differences of leukocyte-platelet interactions and ontreatment platelet reactivity in patients with atherosclerosis. Atherosclerosis 237, 692-5 (2014).
54. Marcantoni, E., Di Francesco, L., Dovizio, M., Bruno, A. & Patrignani, P. Novel insights into the vasoprotective role of heme oxygenase-1. Int. J. Hypertens. 2012, 127910, doi: 10.1155/2012/127910 (2012).
55. Pedram, A. et al. Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol. Biol. Cell. 24, 3805-18 (2013).
56. Franco, A. T., Corken, A. & Ware, J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126, 582-8 (2015).
57. Yu, Y. et al. Gender susceptibility for cigarette smoking-attributable lung cancer: A systematic review and meta-analysis. Lung Cancer 85, 351-360 (2014).
58. Bingham, S. & Riboli, E. Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat. Rev. Cancer 4, 206-15 (2004).
59. Hallmans, G. et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand. J. Public Health Suppl. 61, 18-24 (2003).
60. Hebels, D. G. et al. Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research. Environ Health Perspect. 121, 480-7 (2013).
61. Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics May 8, doi: 10.1186/1471-2105-13-86 (2012).
62. Evans, M., Hastings, N. & Peacock, B. Statistical Distributions, 3rd ed. New York: Wiley, p. 13 (2000).
63. Ward, J. A. et al. Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction. Fam. Med. Med. Sci. Res. October 1, doi: 10.4172/2327-4972.1000108 (2013).
64. Joehanes, R. et al. Gene expression signatures of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 33, 1418-1426 (2013).
65. Nührenberg, T. G. et al. Transcriptome analysis in patients with progressive coronary artery disease: identification of differential gene expression in peripheral blood. J. Cardiovasc. Transl. Res. 6, 81-93 (2013).
66. Masud, R., Shameer, K., Dhar, A., Ding, K. & Kullo, I. J. Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease. J. Clin. Bioinforma. Mar 12, doi: 10.1186/2043-9113-2-6 (2012).
67. Wang, Y. et al. Dysregulated expression of microRNAs and mRNAs in myocardial infarction. Am. J. Transl. Res. 7, 2291-304 (2015).
68. Lewis, D. A. et al. Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb. Res. 135, 659-65 (2015).
69. Jiang, Y. Z., Manduchi, E., Stoeckert, C. J., Jr. & Davies, P. F. Arterial endothelial methylome: differential DNA methylation in atherosusceptible disturbed flow regions in vivo. BMC Genomics Jul 7, doi: 10.1186/s12864-015-1656-4 (2015).
70. Nakai, K. et al. Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry. Hum. Mutat. 20, 133-8 (2002).
71. Melman, Y. F. et al. Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study. Circulation 131, 2202-16 (2015).